Skip to main content
GLMD logo

GLMD · Galmed Pharmaceuticals Ltd.

Track GLMD — free
$0.52 +0.00 (+0.00%)
Market Cap
$4.24M
Shares
8.26M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 14
Total Value: $86,576
Total Shares: 155,725

Institutional Ownership Trend

26 quarters

Holder Concentration

Across 14 13F filers · Δ vs Mar 31, 2026
Top Holder
55.8%
Sep 2023 → Jun 2026 · range 36.1% – 94.0%
+0.8 pts
Top 5
99.9%
Sep 2023 → Jun 2026 · range 89.8% – 99.9%
+2.2 pts
Top 10
100.0%
Sep 2023 → Jun 2026 · range 100.0% – 100.0%
+0.0 pts
HHI
3,985
Sep 2023 → Jun 2026 · range 2,750 – 8,855
Highly concentrated+464

Quarterly Activity

vs Mar 31, 2026
New
2
Increased
2
Decreased
4
Sold Out
4
Unchanged
6
Holder count: -2
Institutional value: +21.2%
Shares held: +6.8%

Top Buyers

vs Mar 31, 2026
Institution Added Now Holds Open

Top Sellers

vs Mar 31, 2026
Institution Sold Now Holds Open

Top New Positions

vs Mar 31, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Mar 31, 2026
Institution Previously Held Last Value (USD) Open
Showing 14 of 14
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1595353 CUSIP M47238148 13F (30d) 13 filings 13 filers Visit website Investor relations